Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Mi Puente: My Bridge to Better Cardiometabolic Health and Well-Being [NA]
Clinical trial update for Mi Puente (My Bridge to Better Cardiometabolic Health and Well-Being) by Scripps Whittier Diabetes Institute; stud…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects [Phase 1, Phase 2]
Phase 1/2 clinical trial exploring the effects of botox on weight loss and glucose tolerance in obese individuals with type 2 diabetes; stud…
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update targeting beta-cell failure in lean patients with type 2 diabetes has completed the study.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects [Phase 4]
A Phase 4 trial assessing the effects of linagliptin on inflammation, oxidative stress, and insulin resistance in obese individuals with Typ…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Penile Length Restoration in Men With Diabetes Mellitus, Type II [NA]
Clinical trial completion reported for penile length restoration in men with type 2 diabetes; results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Managing Diabetes to Gain Opportunities for a More Active Life [NA]
A completed clinical trial study from the University of Chicago focusing on managing type 2 diabetes to enable a more active lifestyle, with…
-
FDA approval · 2023-02-15FDA Tentative Approval: SAXAGLIPTIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA tentatively approves Glenmark's generic saxagliptin (SAXAGLIPTIN) under an ANDA for type 2 diabetes mellitus, subject to patent and excl…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Water Up@ At Home: An Intervention to Replace Sugary Drinks With Water [NA]
A completed trial evaluating an intervention to replace sugary drinks with water in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of ORMD-0801 in subjects with Type 2 Diabetes Mellitus was terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Uric Acid Lowering Trial in Youth Onset T2D [Phase 2]
Phase 2 clinical trial update investigating uric acid lowering in youth-onset type 2 diabetes with diabetic kidney disease and hyperuricemia…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 study of ORMD-0801 in type 2 diabetes mellitus was terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Reinforcement Learning in Diabetes Mellitus Trial [NA]
A completed clinical trial evaluating reinforcement learning approaches for diabetes mellitus type 2 focusing on medication adherence; resul…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial update evaluating efficacy, safety, and pharmacokinetics of CPL207280 in subjects with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Treatment of GLP-1 for Diabetic Bariatric Patients [Phase 4]
A Phase 4 clinical trial update on GLP-1 treatment in diabetic bariatric patients has been terminated with results posted.
-
FDA approval · 2023-02-06FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for Synjardy (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharmaceu…
-
FDA approval · 2023-02-06FDA Approved: SYNJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY XR (empagliflozin/metformin hydrochloride) by Boehringer Ingelheim Pharmaceuticals, Inc…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial updating safety and efficacy data for human insulin recombinant DNA in patients with Type 2 diabetes mellitus.
-
FDA approval · 2023-02-03FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from MannKind Corporation.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes [Phase 3]
Phase 3 trial evaluating the efficacy and safety of co-administration of ATB-1011 with ATB-1012 for essential hypertension and type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of JTT-662 in adults with Type 2 diabetes; study compl…
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes
A long-term study assessing side effects of TRADIANCE in Japanese patients with Type 2 diabetes has completed; results were posted in 2023.
-
FDA approval · 2023-01-19FDA Approved: NATEGLINIDE — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved a supplemental application for nateglinide submitted by Modavar Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus [Phase 4]
Phase 4 trial investigating the effects of evolocumab on platelet reactivity in patients with type 2 diabetes and dyslipidemia; study termin…
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Linagliptin's Effect on CD34+ Stem Cells [Phase 4]
Phase 4 trial assessing linagliptin's effects on CD34+ stem cells in adults with type 2 diabetes and impaired renal function has completed w…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study) [Phase 4]
Phase 4 trial update evaluating empagliFlozin effects on myocardial metabolic rate of glucose estimated by 18FDG PET in adults with type 2 d…